Altered disposition of repeated nicotine doses in rats immunized against nicotine

Nicotine and Tobacco Research

Volumn 1, Issue 3, 1999, Pages 241-249

  Keyler, Daniel E ^a   Hieda, Yoko ^b   Peter, John St ^a   Pentel, Paul R ^c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION STIMULATING AGENT; NICOTINE;

ANIMAL; ARTICLE; BRAIN; DRUG ADMINISTRATION; HALF LIFE TIME; IMMUNOLOGY; MALE; RAT; TISSUE DISTRIBUTION; VACCINATION;

ANIMALS; BRAIN; DRUG ADMINISTRATION SCHEDULE; GANGLIONIC STIMULANTS; HALF-LIFE; MALE; NICOTINE; RATS; TISSUE DISTRIBUTION; VACCINATION;

EID: 0033186759     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622299050011361     Document Type: Article

References (31)

1. Baron JA. 1996. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. British Medical Bulletin 52:58-73.
2. Baud FJ, Sabouraud A, Vicaut E, Taboulet P, Lang J, Bismuth C, Rouzioux JM, Scherrmann JM. 1995. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments. New England Journal of Medicine 332:642-645.
3. Benowitz NL. 1996. Pharmacology of nicotine: addiction and therapeutics. Annual Review of Pharmacology and Toxicology 36:597-613.
4. Benowitz NL, Jacob P. 1984. Daily intake of nicotine during cigarette smoking. Clinical Pharmacology and Therapeutics 35:499-504.
5. Benowitz NL, Hall SM, Herning RI, Jacob P, Jones RT, Osman AL. 1983. Smokers of low-yield cigarettes do not consume less nicotine. New England Journal of Medicine 309:139-142.
6. Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR. 1974. Changes in heroin self-administration by a rhesus monkey after morphine immunization. Nature 252:708-710.
7. Brunn GJ, Keyler DE, Pond SM, Pentel PR. 1992. Reversal of desipramine toxicity in rats using drug-specific antibody Fab fragments: effects on hypotension and interaction with sodium bicarbonate. Journal of Pharmacology and Experimental Therapeutics 260:1392-1399.
8. Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. 1995. Suppression of psychoactive effects of cocaine by active immunization. Nature 378:727-730.
9. Castro A, Monji N, Ali H, Yi M, Bowman ER, McKennis H,Jr., 1980. Nicotine antibodies: comparison of ligand specificities of antibodies produced against two nicotine conjugates. European Journal of Biochemistry 104:331-340s.
10. Cocchetto DM, Bjornsson TD. 1983. Methods for vascular access and collection of body fluids from the laboratory rat. Journal of Pharmaceutical Sciences 72:465-492.
11. Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, Gefter ML, Exley MA, Swain PA, Briner TJ. 1996. Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Medicine 2:1129-1132.
12. Gourlay SG, Benowitz NL. 1997. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clinical Pharmacology and Therapeutics 62:453-463.
13. Harlow E, Lane D. 1988. Antibodies - A Laboratory Manual. Cold Spring Harbor Laboratory 34:290-291.
14. Henningfield JE, Miyasalo K, Jasinski DR. 1985. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. Journal of Pharmacology and Experimental Therapeutics 234:1-12.
15. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. 1993. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug and Alcohol Dependence 33:23-29.
16. Hieda Y, Keyler DE, Vandevoort JT, Kane JK, Ross CA, Raphael DE, Niedbala RS, Pentel PR. 1997. Active immunization alters the plasma nicotine concentration in rats. Journal of Pharmacology and Experimental Therapeutics 283:1076-1081.
17. Hieda Y, Keyler DE, Vandevoort JT, Niedbala RS, Raphael DE, Ross CA, Pentel PR. 1999. Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (in press)
18. Jacob P, Wilson M, Benowitz NL. 1981. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. Journal of Chromatography 222:61-70.
19. Khor SP, Bozigian H, Mayersohn M. 1991. Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat. Drug Metabolism and Disposition 19:486-490.
20. Killian A, Bonese K, Rothberg RM, Wainer BH, Schuster CR. 1978. Effects of passive immunization against morphine on heroin self-administration. Pharmacology, Biochemistry, and Behavior 9:347-352.
21. Langone JJ, Vunakis HV. 1982. Radioimmunoassay of nicotine, cotinine, and y-(3-Pyridyl)-y-oxo-N-methylbutyramide. Methods of Enzymology 84:628-640.
22. Miller RP, Rotenberg KS, Adir J. 1977. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metabolism and Disposition 5:436-443.
23. Muller R. 1983. Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. Methods of Enzymology 92:589-601.
24. Pentel PR, Keyler DE. 1988. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats. Journal of Pharmacology and Experimental Therapeutics 246:1061-1066.
25. Pentel PR, Thompson T, Hatsukami DK, Salerno DM. 1994. 12-lead and continuous ECG recordings of subjects during inpatient administration of smoked cocaine. Drug and Alcohol Dependence 35:107-116.
26. Plowchalk DR, Andersen ME, Debethizy JD. 1992. A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicology and Applied Pharmacology 116:177-188.
27. Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED. 1996. Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology 128:221-226.
28. U.S. Department of Health and Human Services (USDHHS). 1990. The health benefits of smoking cessation: a report of the Surgeon General. DHHS 90-8416:556-559.
29. Valentine JL, Owens SM. 1996. Anti-phencyclidine monoclonal antibodies significantly changes phencyclidine concentrations in brain and other tissues in rats. Journal of Pharmacology and Experimental Therapeutics 278:717-724.
30. Valentine JL, Mayersohn MM, Wessinger WD, Arnold LW, Owens SM. 1996. Anti-phencyclidine monoclonal Fab fragments reverse PCP-induced behavioral effects and ataxia in rats. Journal of Pharmacology and Experimental Therapeutics 278:709-716.
31. Wenger TL, Butler VP, Haber E, Smith TW. 1985. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. Journal of American College of Cardiology 5:118A-123A.